April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJuly 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
Market insights predict, the gene knockdown stable cell line service industry is expected to grow from USD 715 million in 2024 to USD 1557 million by 2034, driven by a CAGR of 8.16%. The market is growing due to the increasing use of stable cell models in drug development, target validation, and functional genomics studies. The strong biotech resea...
April 21, 2026
Based on market forecasts, the global cell and gene therapy tools and reagents market, projected at USD 10.04 billion in 2024, is expected to reach USD 27.3 billion by 2034, growing at a CAGR of 10.76% over the forecast period. The cell and gene therapy tools and reagents market is expanding due to growing CGT clinical trials as well as growing res...
April 21, 2026
Based on market forecasts, the global cell and gene supply chain solutions market, projected at USD 3.54 billion in 2024, is expected to reach USD 14.95 billion by 2034, growing at a CAGR of 15.54% over the forecast period. The cell and gene supply chain solutions market is growing due to the rising need for personalized therapies. North America&rs...
April 21, 2026
According to forecasts, the global drug-induced dyskinesia market will grow from USD 418 million in 2024 to USD 627.5 million by 2034, with an expected CAGR of 4.34%. The market is growing due to the rising prevalence of Parkinsons disease and increased long-term use of dopaminergic therapies. North America dominated the market due to the rising de...
April 21, 2026
Projections indicate that, the global digital health tracking app market will increase from USD 16.11 billion in 2024 to USD 67.97 billion by 2034, experiencing a CAGR of 15.94% over the next 10 years. The market is growing due to rising consumer focus on preventive healthcare and real-time health monitoring. North America is leading the market due...
April 21, 2026
According to market projections, the serum gonadotrophin API sector is expected to grow from USD 131 million in 2024 to USD 202.93 million by 2034, reflecting a CAGR of 4.64%. The market is growing due to rising demand for fertility treatment and assisted reproductive technologies. Additionally, the increasing prevalence of infertility and the expa...
April 21, 2026
The peptide-based weight loss medication market is expanding due to a growing health-conscious population as well as rising muscle-preserving weight loss medications. North America led the market due to the presence of a well-developed healthcare sector....
April 21, 2026
The rising prevalence of chronic disorders and advancements in genomic technologies bolster market growth. North America led the global market owing to the growing demand for biologics and the presence of key players....
April 21, 2026
According to forecasts, the global digital brain health market will grow from USD 231.17 billion in 2024 to USD 478.53 billion by 2034, with an expected CAGR of 7.55%. The accelerating aging population associated with severe neurological issues is boosting the global market expansion. The presence of a well-developed health IT infrastructure is fue...
April 21, 2026
Market insights predict the global drug-loaded fat emulsion industry will increase from USD 2.34 billion in 2024 to USD 7.25 billion by 2034, achieving a CAGR of 12.04%. The principal advantages of these delivery systems, including versatile administration routes, drive the growth of drug-loaded fat emulsions. North America dominated the market in ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
